Masimo (MASI) Return on Capital Employed Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 568.00 |
| Jan 3, 2026 | 506.00 |
| Sep 27, 2025 | -856.00 |
| Jun 28, 2025 | -1,212.00 |
| Mar 29, 2025 | -1,374.00 |
| Dec 28, 2024 | -1,589.00 |
| Sep 28, 2024 | -1,025.00 |
| Jun 29, 2024 | -1,157.00 |
| Mar 30, 2024 | -1,284.00 |
| Dec 30, 2023 | -1,449.00 |
| Sep 30, 2023 | -1,185.00 |
| Jul 1, 2023 | -1,180.00 |
| Apr 1, 2023 | -1,298.00 |
| Dec 31, 2022 | -1,218.00 |
| Oct 1, 2022 | -5,287.00 |
| Jul 2, 2022 | -4,771.00 |
| Apr 2, 2022 | -5,097.00 |
| Jan 1, 2022 | -6,488.00 |
| Oct 2, 2021 | -1,329.00 |
| Jul 3, 2021 | -1,025.00 |
| Apr 3, 2021 | -916.00 |
| Jan 2, 2021 | -901.00 |
| Sep 26, 2020 | -722.00 |
| Jun 27, 2020 | -527.00 |
| Mar 28, 2020 | -391.00 |
| Dec 28, 2019 | -566.00 |
| Sep 28, 2019 | -1,129.00 |
| Jun 29, 2019 | -697.00 |
| Mar 30, 2019 | -457.00 |
| Dec 29, 2018 | -294.00 |
| Sep 29, 2018 | -700.00 |
| Jun 30, 2018 | -611.00 |
| Mar 31, 2018 | -690.00 |
| Dec 30, 2017 | -448.00 |
| Apr 1, 2017 | 3,796.00 |
| Dec 31, 2016 | 5,315.00 |
| Oct 1, 2016 | 123.00 |
| Jul 2, 2016 | -489.00 |
| Apr 2, 2016 | -901.00 |
| Jan 2, 2016 | -1,646.00 |
| Oct 3, 2015 | -1,851.00 |